Cancer
CRISPR-Powered Liquid Biopsies Enhance Early Cancer Diagnosis and Monitoring
Researchers have made significant strides in the development of CRISPR-powered liquid biopsies, which promise to revolutionize cancer screening and diagnosis. By detecting biomarkers in peripheral blood samples, liquid biopsies reduce the need for invasive techniques and provide valuable genetic information essential for the molecular classification of cancers. However, the concentrations